With the well-known fact that blood glucose levels (BGL) fluctuate moment-to-moment, and certainly day-by-day, it might be a bit surprising... Read more »
A reader recently asked about a hormone I had never heard of: "Have you heard of a proposed new drug based on the hormone Irisin?... Read more »
The journal Diabetes Care this month has a fascinating study about basal-bolus insulin therapy for T2DM, titled Adjust to Target in Type 2... Read more »
After attending the Juvenile Diabetes Research Federation (JDRF) Research Summit in Bethesda, Md., sponsored by the Capitol Chapter of... Read more »
For any person with diabetes, deciding to go on a pump is a big decision that involves a careful analysis of the pros and cons of both pump... Read more »
Results from a new U.S. government-sponsored study show that aggressive cholesterol and blood pressure treatments do not reduce the risk of cardiac... Read more »
A recent study analyzed data from 18 clinical trials and found Avandia to be no better at controlling diabetes than other therapies. The study did... Read more »
(Ivanhoe Newswire) -- Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces the risk of developing pancreatic cancer by 62... Read more »
A new study suggests that traditional laser therapy is more effective long-term than steroid injections in treating diabetic macular edema (DME). DME... Read more »
Curing Type 1 diabetes has been a primary goal for stem-cell research since the mid 1990s, but experts say scientists are still years away from... Read more »